Eine ausführliche Publikationsliste finden Sie hier:
Although Japan has been one of the leading markets for medical products, most medical devices are imported to the country. Addressing this circumstance, the Japanese government launched a national STI strategy mentioning biomedical engineering as one focus area to achieve a “healthy and active ageing society as a top-runner in the world” through “reinforcing industrial competitiveness in the areas of pharmaceuticals and medical devices”. Despite the decline in innovation activities since the 1990s, Japan currently experiences a rise of ikō renkei (med-tech partnerships) at the interface between academia, industry and hospitals. This development is strongly supported by the newly established Japan Agency for Medical Research and Development (AMED) and various prefectural governments. By employing a multiple-actor research perspective on (biomedical) research collaborations and regional clusters in Japan, this research aims at exploring the organisation of med-tech partnerships and content of innovation activities as well as their institutional and socioeconomic context.
- Innovation Studies (esp. the Field of Biomedical Engineering / Medical Technologies)
- Science & Technology Studies (STS)
- STI (Science, Technology & Innovation) Governance
- Inter-organisational Collaboration
- Institutional Design, Change and Boundaries
- Technology, Energy and Environmental Policy
Ungleiche Partner, gleiche Interessen? Kooperationen zwischen Unternehmen und zivilgesellschaftlichen Umweltorganisationen in Japan. Monographien aus dem Deutschen Institut für Japanstudien 47. München: iudicium Verlag. 332 S.
[Mit: Wagner, Cosima] Introduction to the Technikstudien — Science & Technology Studies (STS) Research Initiative on Japan.
In: Wagner, Cosima; Brucksch, Susanne (Hg.) Technikstudien and STS: Launching a Research Initiative Regarding Intersections between Technology and Society in Japan. ASIEN 140. pp. 5-21.